Sunday, November 23, 2014 9:06:20 PM
Milestone % of Performance bonus Completion Timing
Nasdaq uplist 30% 12/31/14
Eltoprazine US IND
filed and approved 30% 12/31/14
for LID
LymPro partner
validation of analytical 25% 12/31/14
performance package
(APP) and CLIA
certification
MANF Orphan drug
designation applications 15% 12/31/14
filed and approved for
both ocular ischemic
syndrome (OIA) and
Retinitis pigmentosa
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM